台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    110.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    998
  • 產業
    上櫃 生技醫療類股
  • 307人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-華南永昌-朴子 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-朴子 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/191110.0000.00110.0011,3960.07%
2025/02/140112.0000.00111.5001,4080.00%
2025/02/132111.0000.00111.5021,4130.14%
2025/02/121111.5000.00112.0011,4080.07%
2025/02/110110.5000.00109.0001,3920.00%
2025/02/101119.5000.00118.5011,3370.07%
2025/02/061118.501118.00119.0001,3290.00%
2025/02/0500.004112.13113.00-41,194-0.33%
2025/02/041104.0000.00103.0011,2010.08%
2025/01/22195.6000.0096.1011,1930.08%
2025/01/15195.1000.0093.1011,3800.07%
2025/01/10196.1000.0097.0011,3550.07%
2025/01/0800.001101.00103.00-11,299-0.08%
2025/01/0600.001100.00101.50-11,259-0.08%
2025/01/0300.000.198.0098.30-0.11,240-0.01%
2024/12/2600.00192.1092.50-11,225-0.08%
2024/12/25190.5000.0091.0011,2140.08%
2024/12/20187.9000.0086.2011,2130.08%
2024/12/1300.00089.2088.8001,2090.00%
2024/12/060.193.3000.0093.300.11,1800.01%
2024/12/0400.00194.7094.60-11,164-0.09%
2024/12/0200.00195.0094.40-11,158-0.09%
2024/11/1800.001.196.5796.50-1.11,010-0.11%
2024/11/1100.000103.50103.5008820.00%
2024/11/061106.001102.50102.5008260.00%
2024/11/0100.002109.50105.00-2730-0.27%
2024/10/2900.002.2100.88100.50-2.2604-0.37%
2024/10/28299.50297.30102.0005760.00%
2024/10/24298.90598.3298.30-3494-0.61%
2024/10/23393.9300.0093.7034240.71%
2024/10/0900.00191.1089.50-1508-0.20%
2024/09/2300.00388.0088.00-3620-0.48%
2024/09/20388.40287.9087.4016440.16%
2024/09/19386.3000.0086.0036360.47%
2024/09/0200.000.186.8086.60-0.1719-0.01%
2024/08/21187.0000.0086.6017460.13%
2024/08/08185.4000.0085.4017990.13%
2024/08/05584.86583.8083.0007640.00%
2024/07/1700.00197.8098.20-1658-0.15%
2024/07/1600.00198.1097.00-1658-0.15%
2024/07/15198.00198.4098.4006630.00%
2024/07/09298.0000.0096.3026680.30%
2024/07/081100.001100.50100.5006550.00%
2024/07/03297.1500.0096.7026280.32%
2024/07/02398.1000.0097.8036230.48%
2024/07/0115100.871599.83101.0006100.00%
2024/06/2400.001093.1793.20-10589-1.70%
2024/06/13195.1000.0096.9016510.15%
2024/06/07193.60194.5094.5006440.00%
2024/06/050.192.8000.0092.900.16320.02%
2024/06/0300.00190.9090.70-1693-0.14%
2024/05/21197.0000.0095.1018500.12%
2024/05/170.198.60198.2097.90-0.9872-0.11%
2024/05/16095.2000.0095.1008690.00%
2024/05/0900.00193.5093.30-11,072-0.09%
2024/05/021.194.2900.0094.901.11,4140.08%
2024/04/25192.2000.0090.6011,4490.07%
2024/04/19189.5000.0089.0011,5230.07%
2024/04/1600.00891.0091.00-81,557-0.51%
2024/04/0800.00699.7399.10-61,770-0.34%
2024/03/2800.001100.0099.40-11,839-0.05%
2024/03/271100.00199.7099.7001,8280.00%
2024/03/25199.001100.00101.0001,8160.00%
2024/03/2200.001.195.9396.50-1.11,801-0.06%
2024/03/194.197.33496.2896.800.11,8640.01%
2024/03/1400.00092.9092.7001,8820.00%
2024/03/08895.561198.0695.10-31,924-0.16%
2024/03/0711100.1000.0099.30111,9300.57%
2024/03/0600.00698.4098.10-61,937-0.31%
2024/03/040101.5011100.95100.50-111,924-0.57%
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-15天前
智擎 相關文章